How have ASNB shares performed in 2024?

EKIMAS's stock was trading at $0.62 at the beginning of the year. Since then, ASNB shares have decreased by 1.6% and is now trading at $0.61. View the best growth stocks for 2024 here .

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) issued its earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.02. During the same quarter last year, the business earned $0.27 EPS.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA) , Associated Banc (ASB) , PermRock Royalty Trust (PRT) , CytoDyn (CYDY) , FuelCell Energy (FCEL) , Interpace Biosciences (IDXG) , Sphere 3D (ANY) , AVEO Pharmaceuticals (AVEO) , Boeing (BA) and Bank of America (BAC) .

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)

Free ASNB Stock Alerts

$0.61

0.00 (0.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: $0.61
▼
$0.61
50-Day Range: $0.45
▼
$0.61
52-Week Range: $0.55
▼
$1.75

Volume: N/A
Average Volume: 3,162 shs
Market Capitalization: $3.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get EKIMAS alerts:

Ad Behind the Markets

Better than Bitcoin? The Biotech Stock with 46,751% Potential

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

About EKIMAS

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

ASNB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ASNB Stock News Headlines

March 8, 2023 | finance.yahoo.com

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS

March 1, 2023 | finance.yahoo.com

NORDICUS PARTNERS A/S COMPLETES REVERSE ACQUISITION TRANSACTION WITH EKIMAS CORPORTION

April 25, 2024 | Stansberry Research (Ad)

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

September 14, 2022 | reuters.com

ASNB.PK - Ekimas Corp | Stock Price & Latest News | Reuters

September 12, 2022 | finance.yahoo.com

Updated EKIMAS Corporation Announces Special Cash Distribution

September 10, 2022 | yahoo.com

What does ‘WYLL’ mean on TikTok and Snapchat?

August 28, 2022 | finance.yahoo.com

EKIMAS Corporation (ASNB)

See More Headlines

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/16/2014
Today: 4/25/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:ASNB
Previous Symbol: AMEX:ASB
CUSIP: N/A
CIK: 1011060
Web: www.advbiomaterials.com
Phone: (424) 256-8560
Fax: 978-657-0074
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-290,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -7,902.31%
Return on Assets: -5,274.01%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.12
Quick Ratio: 0.12

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.03 per share
Price / Book: 20.33

Miscellaneous

Outstanding Shares: 5,799,000
Free Float: 5,347,000
Market Cap: $3.54 million
Optionable: Not Optionable
Beta: 0.37

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Henrik Rouf
Chief Executive Officer
Bennett J. Yankowitz
Chief Financial Officer & Director

Key Competitors

View All Competitors

ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed in 2024?: EKIMAS's stock was trading at $0.62 at the beginning of the year. Since then, ASNB shares have decreased by 1.6% and is now trading at $0.61.
View the best growth stocks for 2024 here.
How were EKIMAS's earnings last quarter?: EKIMAS Co. (OTCMKTS:ASNB) issued its earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.02. During the same quarter last year, the business earned $0.27 EPS.
What other stocks do shareholders of EKIMAS own?: Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG), Sphere 3D (ANY), AVEO Pharmaceuticals (AVEO), Boeing (BA) and Bank of America (BAC).
How do I buy shares of EKIMAS?: Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ASNB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial